If some autoinjectors are used with glatiramer acetate injections, there is an increased risk for medication errors, including a missed dose or partial administration, the agency said May 16.
Teva Pharmaceuticals’ Copaxone does not have a compatible autoinjector device and can only be used as the prefilled syringe; Sandoz’ Glatopa is solely compatible with Glatopaject; and Viatris/Mylan’s glatiramer acetate injection is only compatible with WhisperJECT. The FDA said these are the only therapies with compatibility constrictions.
